LncRNA-UCA1 increases cisplatin resistance during bladder cancer chemotherapy by increasing the expression of Wnt6 and thus represents a potential target to overcome bladder cancer chemoresistance [15]. This evidence concerns the gene WNT6 and urinary bladder cancer.